Please login to the form below

Not currently logged in
Email:
Password:

Epidarex

This page shows the latest Epidarex news and features for those working in and with pharma, biotech and healthcare.

Novartis invests $1.3bn in protein degradation technology

Novartis invests $1.3bn in protein degradation technology

Dunad, which was only founded last year, is backed by founding investor Epidarex Capital as well as BioGeneration Ventures.

Latest news

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • IGEM Therapeutics appoints Dr Tim Wilson as CEO IGEM Therapeutics appoints Dr Tim Wilson as CEO

    has raised £2m from Epidarex Capital, in order to progress its pipeline of IgE antibody drug candidates. ... Dr Peter Finan, venture partner and Epidarex Capital, said: “We are very pleased to have been able to recruit Dr Tim Wilson to lead IGEM as CEO

  • Caldan Therapeutics appoints CEO Caldan Therapeutics appoints CEO

    Dr Liz Roper, partner at Epidarex Capital, which backs Caldan Therapeutics, said: “We are delighted to welcome Mark on board to lead Caldan Therapeutics moving forward.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
foxandcat.online

We help communications teams to thrive under pressure. Here at fox&cat, we help all kinds of teams to fight all...

Latest intelligence

Our Top 5 Pharma Picks From Cannes Lions
Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
The Evolving Role of the Sales Rep
The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
Measure your omnichannel maturity with our new tool
Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....